Raymond James & Associates Sells 33,843 Shares of Azenta, Inc. (NASDAQ:AZTA)

Raymond James & Associates lessened its holdings in shares of Azenta, Inc. (NASDAQ:AZTA) by 30.5% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 77,105 shares of the company’s stock after selling 33,843 shares during the quarter. Raymond James & Associates owned approximately 0.14% of Azenta worth $3,735,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Kayne Anderson Rudnick Investment Management LLC raised its position in Azenta by 1.9% during the second quarter. Kayne Anderson Rudnick Investment Management LLC now owns 5,298,040 shares of the company’s stock valued at $278,783,000 after acquiring an additional 100,826 shares in the last quarter. Dimensional Fund Advisors LP grew its holdings in Azenta by 16.5% during the second quarter. Dimensional Fund Advisors LP now owns 2,970,964 shares of the company’s stock valued at $156,331,000 after purchasing an additional 421,719 shares during the last quarter. Allspring Global Investments Holdings LLC grew its holdings in Azenta by 5.3% during the second quarter. Allspring Global Investments Holdings LLC now owns 1,115,816 shares of the company’s stock valued at $58,714,000 after purchasing an additional 56,387 shares during the last quarter. Bank of New York Mellon Corp grew its holdings in Azenta by 3.8% during the second quarter. Bank of New York Mellon Corp now owns 515,393 shares of the company’s stock valued at $27,120,000 after purchasing an additional 18,680 shares during the last quarter. Finally, Federated Hermes Inc. grew its holdings in Azenta by 6.3% during the second quarter. Federated Hermes Inc. now owns 432,506 shares of the company’s stock valued at $22,758,000 after purchasing an additional 25,586 shares during the last quarter. Institutional investors own 99.08% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have commented on the company. Needham & Company LLC reiterated a “buy” rating and set a $69.00 price target on shares of Azenta in a report on Wednesday, August 7th. Evercore ISI lowered their price target on Azenta from $53.00 to $50.00 and set an “in-line” rating on the stock in a report on Tuesday, October 1st. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $66.40.

Insider Transactions at Azenta

In other news, CFO Herman Cueto sold 1,595 shares of the firm’s stock in a transaction on Thursday, October 17th. The shares were sold at an average price of $43.68, for a total value of $69,669.60. Following the sale, the chief financial officer now owns 24,604 shares in the company, valued at approximately $1,074,702.72. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 1.77% of the stock is currently owned by corporate insiders.

Azenta Stock Up 0.3 %

Shares of AZTA stock opened at $41.22 on Monday. The business’s 50 day moving average is $46.31 and its two-hundred day moving average is $50.92. The company has a market cap of $2.02 billion, a PE ratio of -14.67 and a beta of 1.48. Azenta, Inc. has a 12 month low of $40.24 and a 12 month high of $69.16.

Azenta (NASDAQ:AZTA) last announced its quarterly earnings data on Tuesday, August 6th. The company reported $0.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.07 by $0.09. The business had revenue of $173.00 million for the quarter, compared to the consensus estimate of $166.14 million. Azenta had a negative net margin of 23.66% and a positive return on equity of 0.89%. Azenta’s quarterly revenue was up 4.2% on a year-over-year basis. During the same quarter last year, the company posted $0.13 earnings per share. As a group, equities analysts expect that Azenta, Inc. will post 0.33 EPS for the current fiscal year.

Azenta Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.